YY1 downregulation restored the expression of myeloid C/EBP transcription factors and growth factors; increased the availability of RARα, making cells more sensitive to ATRA exposure; and restored apoptosis in AML cell lines. This evidence concerns the gene YY1 and acute myeloid leukemia.